NCT02216773View on ClinicalTrials.gov

Regeneration of Liver: Portal Vein Embolization Versus Radiofrequency Assisted Ligation for Liver Hypertrophy (REBIRTH)

NACompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

April 30, 2018

Study Completion Date

April 30, 2018

Conditions
Liver ResectionCancer
Interventions
PROCEDURE

Radiofrequency assisted liver partition with portal vein ligation (RALPP)

PROCEDURE

Portal vein embolization (PVE)

Trial Locations (1)

W12 0HS

Hammersmith Hospital, London

All Listed Sponsors
lead

Imperial College London

OTHER

NCT02216773 - Regeneration of Liver: Portal Vein Embolization Versus Radiofrequency Assisted Ligation for Liver Hypertrophy (REBIRTH) | Biotech Hunter | Biotech Hunter